These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3987077)

  • 21. Carrier detection in X-linked Becker muscular dystrophy by muscle provocation test (MPT).
    Herrmann FH; Spiegler AW
    J Neurol Sci; 1983 Dec; 62(1-3):141-6. PubMed ID: 6668470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimates of conditional heterozygosity risks for young females in Duchenne muscular dystrophy.
    Passos-Bueno MR; Otto PA; Zata M
    Hum Hered; 1989; 39(4):202-11. PubMed ID: 2583732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Computerized tomography findings in malignant progressive Duchenne muscular dystrophy].
    Gellerich I; Koch RD
    Psychiatr Neurol Med Psychol (Leipz); 1990 May; 42(5):282-90. PubMed ID: 2388956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy.
    Hyser CL; Griggs RC; Mendell JR; Polakowska R; Quirk S; Brooke MH; Fenichel GM; Doherty RA
    Neurology; 1987 Jan; 37(1):4-10. PubMed ID: 2879259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histochemically demonstrable fibre abnormalities in normal skeletal muscle and in muscle from carriers of Duchenne muscular dystrophy.
    Morris CJ; Raybould JA
    J Neurol Neurosurg Psychiatry; 1971 Jun; 34(3):348-52. PubMed ID: 4328368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of flanking markers in prediction for Duchenne muscular dystrophy.
    Williams H; Sarfarazi M; Brown C; Thomas N; Harper PS
    Arch Dis Child; 1986 Mar; 61(3):218-22. PubMed ID: 3457554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progression of muscular dystrophy assessed by computed tomography.
    Stern LM; Caudrey DJ; Perrett LV; Boldt DW
    Dev Med Child Neurol; 1984 Oct; 26(5):569-73. PubMed ID: 6510558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative analysis of quadriceps muscle biopsy. Results in 7 definite and 45 possible carriers of Duchenne muscular dystrophy.
    Doriguzzi C; Palmucci L; Mongini T; Leone M; Gagnor E; Gagliano A; Schiffer D
    J Neurol Sci; 1986 Feb; 72(2-3):201-9. PubMed ID: 3711934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carrier detection in Duchenne muscular dystrophy.
    Nicholson GA; Gardner-Medwin D; Walton JN
    Lancet; 1979 Aug; 2(8138):367. PubMed ID: 89433
    [No Abstract]   [Full Text] [Related]  

  • 30. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy.
    Drummond LM
    Arch Dis Child; 1979 May; 54(5):362-6. PubMed ID: 475411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum creatine kinase activity and carrier status for duchenne muscular dystrophy.
    Bullock DG; McSweeney FM; Whitehead TP; Edwards JH
    Lancet; 1979 Dec 22-29; 2(8156-8157):1370. PubMed ID: 92710
    [No Abstract]   [Full Text] [Related]  

  • 32. Computed tomographic patterns of pseudohypertrophic muscular dystrophy: preliminary results.
    O'Doherty DS; Schellinger D; Raptopoulos V
    J Comput Assist Tomogr; 1977 Oct; 1(4):482-6. PubMed ID: 615228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymptomatic hyperCKemia: detection of an isolated carrier of Duchenne muscular dystrophy.
    Tachi N; Wakai S; Yutoh Y; Chiba S; Miura J
    J Child Neurol; 1990 Oct; 5(4):351-3. PubMed ID: 2246492
    [No Abstract]   [Full Text] [Related]  

  • 34. [Distribution of skeletal muscle involvement in autosomal recessive distal muscular dystrophy: a clinical and computed tomographic study].
    Mizusawa H; Kobayashi F; Nakanishi T
    Rinsho Shinkeigaku; 1987 Feb; 27(2):177-84. PubMed ID: 3581592
    [No Abstract]   [Full Text] [Related]  

  • 35. [Computed tomography in Duchenne type muscular dystrophy--morphological stages based on the computed tomographical findings].
    Kawai M; Kunimoto M; Motoyoshi Y; Kuwata T; Nakano I
    Rinsho Shinkeigaku; 1985 May; 25(5):578-90. PubMed ID: 4028577
    [No Abstract]   [Full Text] [Related]  

  • 36. Carrier detection in Duchenne muscular dystrophy.
    Carter CO
    Lancet; 1979 May; 1(8123):979. PubMed ID: 87648
    [No Abstract]   [Full Text] [Related]  

  • 37. [Muscle CT in Duchenne muscle dystrophy in infants].
    Takahashi R; Matsui K; Fukushima N; Kurokawa T
    No To Hattatsu; 1992 Sep; 24(5):496-8. PubMed ID: 1389336
    [No Abstract]   [Full Text] [Related]  

  • 38. A new method for the analysis of age trends in CPK levels with application to Duchenne muscular dystrophy.
    Lange K; Zatz M
    Hum Hered; 1979; 29(3):154-60. PubMed ID: 468274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation.
    Maunder-Sewry CA; Dubowitz V
    J Neurol Sci; 1981 Feb; 49(2):305-24. PubMed ID: 6452514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.